Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07830888) titled 'Mitral Valve Prolapse Arrhythmic Risk' on Sept. 15.

Study Type: Observational

Primary Sponsor: Oslo University Hospital

Condition: Mitral Valve Prolapse Ventricular Arrhythmias and Cardiac Arrest

Intervention: Other: Risk prediction model

Recruitment Status: Recruiting

Date of First Enrollment: August 7, 2026

Target Sample Size: 500

Countries of Recruitment: Norway

To know more, visit https://clinicaltrials.gov/study/NCT07830888

Published by HT Digital Content Services with permission from Health Daily Digest....